Colgate-Palmolive's first quarter 2026 organic sales growth of 2.9% missed estimates, prompting a cut to full-year margin guidance.

Colgate-Palmolive reported first quarter 2026 revenue of $5.32 billion, a slight miss against the $5.38 billion consensus estimate, while non-GAAP EPS of $0.97 beat expectations by $0.02. The company's organic sales growth of 2.9% fell significantly short of the 7.2% analyst forecast, driven by a decline in North America.

Key Highlights

• Organic sales grew 2.9%, a notable miss versus the 7.2% consensus, reflecting a slowdown from prior periods. The result was negatively impacted by a 2.2% decline in North America and moderating growth in the Hill's Pet Nutrition segment (+2.1%).
• The company lowered its full-year 2026 guidance for gross profit margin, now expecting a decline for the year versus a previously guided increase.
• Emerging markets remained a source of strength, with Latin America and Asia Pacific reporting organic sales growth of 5.4% and 5.6%, respectively.